Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.

Barasch N, Gong X, Kwei KA, Varma S, Biscocho J, Qu K, Xiao N, Lipsick JS, Pelham RJ, West RB, Pollack JR.

PLoS One. 2017 Feb 17;12(2):e0171265. doi: 10.1371/journal.pone.0171265. eCollection 2017.

2.

Searching for mammary analogue [corrected] secretory carcinoma of salivary gland among its mimics.

Pinto A, Nosé V, Rojas C, Fan YS, Gomez-Fernandez C.

Mod Pathol. 2014 Jan;27(1):30-7. doi: 10.1038/modpathol.2013.84. Epub 2013 Jun 28. Erratum in: Mod Pathol. 2014 Jun;27(6):918.

3.

High-grade transformation of acinic cell carcinoma: an inadequately treated entity?

Chintakuntlawar AV, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins SM, Davidson JA, Keeney MG, Rivera M, Price DL, Moore EJ, Olsen KD, Kasperbauer JL, Foote RL, Price KA, García JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May;121(5):542-549.e1. doi: 10.1016/j.oooo.2016.01.011. Epub 2016 Jan 21.

PMID:
27017401
4.

Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.

Kawahara A, Taira T, Abe H, Takase Y, Kurita T, Sadashima E, Hattori S, Imamura I, Matsumoto S, Fujisaki H, Sueyoshi K, Akiba J, Kage M.

Cancer Cytopathol. 2015 Oct;123(10):603-11. doi: 10.1002/cncy.21594. Epub 2015 Aug 7.

5.

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.

Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK.

Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.

6.

Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.

Urano M, Nagao T, Miyabe S, Ishibashi K, Higuchi K, Kuroda M.

Hum Pathol. 2015 Jan;46(1):94-103. doi: 10.1016/j.humpath.2014.09.012. Epub 2014 Oct 7.

PMID:
25456394
7.

Cytopathologic features of mammary analogue secretory carcinoma.

Bishop JA, Yonescu R, Batista DA, Westra WH, Ali SZ.

Cancer Cytopathol. 2013 May;121(5):228-33. doi: 10.1002/cncy.21245. Epub 2012 Oct 5.

8.

Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.

Weinreb I, Zhang L, Tirunagari LM, Sung YS, Chen CL, Perez-Ordonez B, Clarke BA, Skalova A, Chiosea SI, Seethala RR, Waggott D, Boutros PC, How C, Liu FF, Irish JC, Goldstein DP, Gilbert R, Ud Din N, Assaad A, Hornick JL, Thompson LD, Antonescu CR.

Genes Chromosomes Cancer. 2014 Oct;53(10):845-56. doi: 10.1002/gcc.22195. Epub 2014 Jun 18.

PMID:
24942367
9.

Are acinic cell carcinomas of the breast and salivary glands distinct diseases?

Piscuoglio S, Hodi Z, Katabi N, Guerini-Rocco E, Macedo GS, Ng CK, Edelweiss M, De Mattos-Arruda L, Wen HY, Rakha EA, Ellis IO, Rubin BP, Weigelt B, Reis-Filho JS.

Histopathology. 2015 Oct;67(4):529-37. doi: 10.1111/his.12673. Epub 2015 Mar 23.

10.

Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.

Connor A, Perez-Ordoñez B, Shago M, Skálová A, Weinreb I.

Am J Surg Pathol. 2012 Jan;36(1):27-34. doi: 10.1097/PAS.0b013e318231542a.

PMID:
21989350
11.

Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma.

Diegel CR, Cho KR, El-Naggar AK, Williams BO, Lindvall C.

Cancer Res. 2010 Nov 15;70(22):9143-52. doi: 10.1158/0008-5472.CAN-10-1758. Epub 2010 Nov 9.

12.

Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.

Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z, Michal M.

Am J Surg Pathol. 2010 May;34(5):599-608. doi: 10.1097/PAS.0b013e3181d9efcc.

PMID:
20410810
13.

MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.

Rettig EM, Tan M, Ling S, Yonescu R, Bishop JA, Fakhry C, Ha PK.

Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.

14.

The importance of dedifferentiation in recurrent acinic cell carcinoma.

Timon CI, Dardick I.

J Laryngol Otol. 2001 Aug;115(8):639-44.

PMID:
11535145
15.

[Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].

Sun H, Wu S, Ouyang J.

Zhonghua Kou Qiang Yi Xue Za Zhi. 1999 Sep;34(5):289-91. Chinese.

PMID:
11776895
16.

CHCHD7-PLAG1 and TCEA1-PLAG1 gene fusions resulting from cryptic, intrachromosomal 8q rearrangements in pleomorphic salivary gland adenomas.

Asp J, Persson F, Kost-Alimova M, Stenman G.

Genes Chromosomes Cancer. 2006 Sep;45(9):820-8.

PMID:
16736500
17.

[Clinicopathologic features of mammary analogue secretory carcinoma of salivary glands].

Zhang XP, Ni H, Wang X, Chen H, Shi SS, Yu B, Zhou XJ, Rao Q.

Zhonghua Bing Li Xue Za Zhi. 2017 Jan 8;46(1):34-37. doi: 10.3760/cma.j.issn.0529-5807.2017.01.008. Chinese.

PMID:
28072974
18.

Demonstration of c-erbB-2 oncogene overexpression in salivary gland neoplasms by in situ hybridization.

Jordan R, Dardick I, Lui E, Birek C.

J Oral Pathol Med. 1994 May;23(5):226-31.

PMID:
7913972
19.

WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.

Queimado L, Lopes CS, Reis AM.

Genes Chromosomes Cancer. 2007 Mar;46(3):215-25.

PMID:
17171686
20.

Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence.

Ramachandran I, Ganapathy V, Gillies E, Fonseca I, Sureban SM, Houchen CW, Reis A, Queimado L.

Cell Death Dis. 2014 May 22;5:e1246. doi: 10.1038/cddis.2014.219.

Supplemental Content

Support Center